Cullinan Oncology financial statements

컬리넌 테라퓨틱스NASDAQ:CGEM · Nasdaq · Healthcare · sector #16
$16.25+1.31%
2026-10-06 close · prelim

Cullinan Oncology's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$197M.

Reported results

Cullinan Oncology notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q